Simultaneous quantitation of R-and S-CHBA metabolite and racemic baclofen in human plasma and cerebrospinal fluid using Liquid chromatographic and mass spectrometric (LC/MS) conditions R-and S-CHBA and racemic baclofen assay: Chromatographic separations were performed using a Chiralcel OJ R-RH column (2.1mm x150 mm, 5 μ, Daicel Chemical Industries, Ltd., Japan) along with a C18 guard column (EVO-C18; 2.1 mm internal diameter, Phenomenex, Torrance, CA.). The system was operated in isocratic mode with a mobile phase composed of 0.4% formic acid in water and 0.4% FA in ACN (84:16, v/v) operated at a flow rate of 1.0 mL/min. The chromatographic separation was achieved using a 27 minute total run time. A 10 μL injection volume was adopted for all samples.
Post-column infusion of 0.5% ammonium hydroxide (NH4OH) in water and ACN (80:20, v/v) operated at 0.1 mL/min was performed using a 3-way connector after the column and prior to mass detection.
The MS parameters were optimized using the auto-optimization method as implemented in the LabSolutions software Version 5.6 (Shimadzu Scientific, Inc, Columbia, MD, USA). The final parameters for each analyte and IS are shown in Table 1 . LabSolutions software Version 5.6 was used to perform data acquisition and quantitation.
Preparation of stock, calibration standards and quality control samples
Stock solutions of R-and S-baclofen, R-CHBA, and S-CHBA were prepared by dissolving 1 mg of each compound into 1 mL water. The stock solutions were transferred to an eppendorf vial and stored at -20℃ for future use.
For quantitation of total racemic baclofen and individual R-and S-CHBA isomers, the same CCs and QCs were reinjected on the metabolite separation method. Concentrations of CCs ranged from 1 to 2000 ng/mL for R-and S-CHBA and from 2 to 4000 ng/mL for racemic baclofen. QCs for racemic baclofen include 2 ng/mL LLOQ, 10 ng/mL of LQC, 1000 ng/mL of MQC and 3000 ng/mL of HQC. The corresponding concentrations for R-and S-CHBA were half that for the total racemic baclofen. The QCs concentration and assay performance are shown in Table 3 . All the samples were kept at -20 °C until analysis.
For the internal standard, 1 mg/mL stock solution of Baclofen-d4 (racemic) was prepared by dissolving 1 mg in 1 mL water. The sample was transferred to an eppendorf vial and stored at -20℃ for future use. When preparing the working IS stock solution, the baclofen d4 was diluted with 50% methanol to make a 5 µ g/mL solution.
Assay Validation
The developed LC-MS/MS assay for R-and S-CHBA separation was validated for sensitivity, selectivity, accuracy and precision in plasma according to the current FDA guidelines [25] .
Using a Chiralcel column to separate R-and S-CHBA metabolites and total baclofen, the %RSD of inter-day precision values for QC samples were between 3.3 to 18.7% with intra-day precision values ranging from 1.7 to 9.7%, which indicated acceptable assay precision ( Supplementary Table  1 ). Supplementary Table 1 . Intra and inter-day precision (% RSD) and accuracy (% bias) for baclofen and its metabolites in human plasma.
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